27 April 1945: The provisional #Austria n govt nullifies the Anschluss, reestablishing an independent, democratic #Austria under the 1920 constitution. Germany surrenders on May 8. Austria is occupied by the allies until 1955. #OTD #WW2 #ad amzn.to/3zy43J1

Assessment of adherence in diabetics revealed what we already knew: lipid-lowering therapies are unpopular. Please find our study using mass spectrometry to assess drug metabolites in the urine of 1125 patients. Led by the amazing Dr. Denicolo (link.springer.com/article/10.100…)

The second Austrian Mayo Clinic meeting is happening in 18 days in the 'Mozart' city Salzburg. It is not too late to register for this event: mayoclinic.congressinfo.eu
We are looking forward to two days of networking and discussions.

Amazing sub-study from EMPA-KIDNEY focusing on the Japanese patients! A striking risk reduction is reported!

🫘✅Management of adult FSGS

NDT Hans-Joachim Anders

academic.oup.com/ndt/article/39…

👍So many new drugs in pipeline

Don’t feel fatigued when watching this! A huge unmet need in nephrology! Thanks to L. Parker Gregg and others, research will hopefully help us to improve it!

✅ It is my IMMENSE PLEASURE to share with you our SEMINAR on systemic #Lupus just published in... The LANCET!!!!! Amazing work driven by Alberta Hoi 👍
LINK: authors.elsevier.com/a/1ixq7V-4XOrME

Thank you Maine-Anjou AAV-GN Research Group for highlighting the article. The Appendix focuses on CKD and CVD management. Not enough space to discuss these fascinating diseases!

Great news Jochen Reiser MD PhD and Walden Biosciences! A P2 is certainly needed to understand the impact of anti-suPAR treatment on proteinuria in proteinuric kidney diseases

Every single flare of LN increases the risk of non-response to treatment, development of CKD and KF! A piece led by Eleni Frangou and published in JASN_News! A pleasure to work with these amazing co-authors as tagged by Hans-Joachim Anders

To diagnose anti-GBM disease in the absence of circulating antibodies remains a big challenge. Our response to this recent paper in AJKD (sciencedirect.com/science/articl…) can be found here (sciencedirect.com/science/articl…). It needs more stringent criteria to make such a diagnosis

🫘Differentials of linear IgG staining along glom basement membrane

🎯Anti GBM

🎯Diabetic kidney disease

🎯Monoclonal Immunoglobulin deposit disease

🎯Fibrillary GN

ajkd.org/article/S0272-…

AJKD

Defining responses criteria in #ANCA vasculitis. 1st step: identify what has already been used in published/ongoing clinical trials… and they found so much heterogeneity (both on clinical and timing endpoints)! Dr. KA. Quinn #vasculitisBCN2024

Save the date! Thanks to Kitching Laboratory for organizing the next vasculitis workshop!

Is every linear staining anti-GBM disease? What is 'atypical' anti-GBM disease & when is it something completely different? Read the study by Chauveau et al., editorial by Lynn D. Cornell, M.D. & our comment by Tiffany Caza & Andreas Kronbichler published in AJKD

ajkd.org/article/S0272-…

Amazing study by Maine-Anjou AAV-GN Research Group on ANCA-GN following kidney transplantation!

First presentation of the early renal recovery data from PEXIVAS today in the plenary session by Balazs Odler . A big thank you to the PIs of the tria (@lastwalsh Dr Merkel and David Jayne); brilliant and clear presentation of the results!

Brilliant presentation Balazs Odler !
How does plasma exchange affect early renal improvement in AAV patients.
Tailored treatment is the best approach. Looking forward to the publication!
#VasculitisBCN2024
#vasculitis #pexivas
Vasculitis UK - In memory of John Mills MBE 💙💚 VIA Vasculitis Stichting _ERNRITA

Post-hoc PEXIVAS analysis: no effect of reduced GC dose on kidney recovery. Faster kidney recovery with PLEX but no sustained effect beyond 3 months.
1️⃣ real PLEX effect vs convection effect?
2️⃣ how about stratification by histological class? Balazs Odler #vasculitisBCN2024

Fokko van der Woude will always be remembered for his landmark study in The Lancet in 1985! Over the past 4 decades, vasculitis research was outstanding when it comes to clinical trials, observational studies and overall studies focusing on improving prognosis!